ConductScience.org, home

Paper317254

Multicentre trials of praziquantel in human schistosomiasis: design and techniques.

Davis A and 1 other. Bull World Health Organ, 1979. Cited by 83 papers, by iCite.

Cite this record

ConductScience Library. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Papers, record 317254. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/317254

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multicentre trials of praziquantel in human schistosomiasis: design and techniques.
PubMed
Journal
Bull World Health Organ
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
83
iCite
Relative citation ratio, by iCite
3.75
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davis AA
2Wegner DHD H

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Clinical Trials as TopicMajor topic
IsoquinolinesMajor topic
PraziquantelMajor topic
SchistosomiasisMajor topic
Double-Blind Method
Female
Humans
Male
World Health Organization

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1410178Praziquantel, a new board-spectrum antischistosomal agent.Z Parasitenkd1977https://conductscience.org/library/papers/410178PubMed
2396055Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections.Bull World Health Organ1979https://conductscience.org/library/papers/396055PubMed
3334117Mutagenicity studies with praziquantel, a new anthelmintic drug: tissue-, host-, and urine-mediated mutagenicity assays.Arch Toxicol1977https://conductscience.org/library/papers/334117PubMed
4580366Mutagenicity studies with praziquantel, a new anthelmintic drug, in mammalian systems.Arch Toxicol1978https://conductscience.org/library/papers/580366PubMed
5926185Carcinogenic effects of niridazole on rodents infected with Schistosoma mansoni.J Natl Cancer Inst1977https://conductscience.org/library/papers/926185PubMed
6906624A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei im hamsters.Z Parasitenkd1977https://conductscience.org/library/papers/906624PubMed
7906623The efficacy of praziquantel against cestodes in animals.Z Parasitenkd1977https://conductscience.org/library/papers/906623PubMed
81235062Carcinogenic effects of niridazole.Cancer Lett1975https://conductscience.org/library/papers/1235062PubMed
9180276Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.J Pharmacol Exp Ther1976https://conductscience.org/library/papers/180276PubMed
104413726Hycanthone analogs: dissociation of mutagenic effects from antischistosomal effects.Science1974https://conductscience.org/library/papers/4413726PubMed

Download CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.

PMIDTitleJournalYearIn PapersSource
36278582Swiss-Chinese Cooperation in Tropical Medicine: The Role of Professor Marcel Tanner.Diseases2022https://conductscience.org/library/papers/36278582PubMed
35448830Schistosomiasis at the Crossroad to Elimination: Review of Eclipsed Research with Emphasis on the Post-Transmission Agenda.Trop Med Infect Dis2022https://conductscience.org/library/papers/35448830PubMed
33508096The history of the neglected tropical disease movement.Trans R Soc Trop Med Hyg2021https://conductscience.org/library/papers/33508096PubMed
33116680Genetic Diversity of Schistosoma haematobium in Qena Governorate, Upper Egypt.Infect Drug Resist2020https://conductscience.org/library/papers/33116680PubMed
32730343Cloning and functional complementation of ten Schistosoma mansoni phosphodiesterases expressed in the mammalian host stages.PLoS Negl Trop Dis2020https://conductscience.org/library/papers/32730343PubMed
32400351Schistosomiasis Consortium for Operational Research and Evaluation: Mission Accomplished.Am J Trop Med Hyg2020https://conductscience.org/library/papers/32400351PubMed
32106428Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs.Biomolecules2020https://conductscience.org/library/papers/32106428PubMed
31060317Schistosomiasis Elimination: Beginning of the End or a Continued March on a Trodden Path.Trop Med Infect Dis2019https://conductscience.org/library/papers/31060317PubMed
30736431Elimination of Schistosomiasis Mekongi from Endemic Areas in Cambodia and the Lao People's Democratic Republic: Current Status and Plans.Trop Med Infect Dis2019https://conductscience.org/library/papers/30736431PubMed
30572592Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis.Trop Med Infect Dis2018https://conductscience.org/library/papers/30572592PubMed
28793922Comparison of novel and standard diagnostic tools for the detection of Schistosoma mekongi infection in Lao People's Democratic Republic and Cambodia.Infect Dis Poverty2017https://conductscience.org/library/papers/28793922PubMed
28351414Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?Infect Dis Poverty2017https://conductscience.org/library/papers/28351414PubMed
26174621Can human schistosomiasis mansoni control be sustained in high-risk transmission foci in Egypt?Parasit Vectors2015https://conductscience.org/library/papers/26174621PubMed
25099517Drugs for treating urinary schistosomiasis.Cochrane Database Syst Rev2014https://conductscience.org/library/papers/25099517PubMed
12709312Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials.Antimicrob Agents Chemother2003https://conductscience.org/library/papers/12709312PubMed
11076716Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya.Emerg Infect Dis2000https://conductscience.org/library/papers/11076716PubMed
7222647Schistosomiasis: recent developments in immunology and treatment.West J Med1980https://conductscience.org/library/papers/7222647PubMed
6973414The schistosomiasis problem in the world: results of a WHO questionnaire survey.Bull World Health Organ1981https://conductscience.org/library/papers/6973414PubMed
6794779The six diseases of WHO. Schistosomiasis: some advances.Br Med J (Clin Res Ed)1981https://conductscience.org/library/papers/6794779PubMed
3551827Clinical study evaluating efficacy of praziquantel in clonorchiasis.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3551827PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/317254

GET https://conductscience.org/api/papers/v1/317254/cited_by?page=2